4//SEC Filing
LIGAND PHARMACEUTICALS INC 4
Accession 0001247741-04-000037
$LGNDCIK 0000886163operating
Filed
May 26, 8:00 PM ET
Accepted
May 27, 5:34 PM ET
Size
7.3 KB
Accession
0001247741-04-000037
Insider Transaction Report
Form 4
CROSS ALEXANDER D
Director
Transactions
- Sale
Common Stock
2004-05-27$21.00/sh−1,000$21,000→ 6,001 total(indirect: By Trust) - Sale
Common Stock
2004-05-26$21.00/sh−1,000$21,000→ 7,001 total(indirect: By Trust)
Holdings
- 24,494
Common Stock
Footnotes (1)
- [F1]Sale effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 19, 2004.
Documents
Issuer
LIGAND PHARMACEUTICALS INC
CIK 0000886163
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000886163
Filing Metadata
- Form type
- 4
- Filed
- May 26, 8:00 PM ET
- Accepted
- May 27, 5:34 PM ET
- Size
- 7.3 KB